MEK inhibitors in oncology: a patent review and update (2016 - present)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MEK inhibitors in oncology: a patent review and update (2016 - present)

Published:2024-09-14 Issue: Volume: Page:
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Suryavanshi Anjali¹,Vandana ¹,Shukla Yugal Kishor¹,Kumar Vipul²,Gupta Pragya¹,Asati Vivek³,Mahapatra Debarshi Kar¹,Keservani Raj K.⁴,Jain Sanmati Kumar¹,Bharti Sanjay Kumar¹

Affiliation:

1. Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India

2. Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), Delhi Pharmaceutical Sciences and Research University, New Delhi, India

3. Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India

4. Faculty of B. Pharmacy, CSM Group of Institutions, Prayagraj, Uttar Pradesh, India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2024.2403634

Reference162 articles.

1. Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway

2. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases

3. Hybrid Quinazoline 1,3,5‐Triazines as Epidermal Growth Factor Receptor (EGFR) Inhibitors with Anticancer Activity: Design, Synthesis, and Computational Study

4. Development of anticancer drugs targeting the MAP kinase pathway

5. Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine–sulfonamide hybrids as selective BRAF^V600E inhibitors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP